Operators and partners
Programs adopted across these licensed Israeli operators between 2008 and the early 2020s.
Selected coverage
"He pushed through cannabis as medicine in Israel, now he'll convince MPs in Czechia"
Coverage of Gil's address to the Czech Parliament's Health Committee in the run-up to the Czech Republic's 2013 legalization of medicinal cannabis.
Czech Parliament address coverage
National public-radio coverage of the Parliament visit and the Israeli model of patient education.
CannaTech Tel Aviv 2016
One of the first international cannabis-industry conferences in Israel. Speaker on patient education and Israeli regulatory practice.
Hebrew-language press archive
Two decades of Hebrew-press coverage of Gil's work with IMCA, the Knesset medical-cannabis lobby, and operator-side adoption of patient-education programs. Original-language sources available on request.
US tour — Colorado, Oregon, California
15-day visit to lay groundwork for international cannabis trade. Coverage in regional industry press; details on request.
US Patent US11346051B2 grant
Patent for "Aromatized and flavored paper products" — the cold terpene-printing technology developed with Cannaboost.
Media kit and booking
Podcast or interview booking
Topics I speak on with depth: patient accountability in the AI era; cannabis as a complex system; what Israel got right (and wrong) in 20 years of medical cannabis; the gap between patient education and patient compliance.
Format: 45-90 min remote interviews, recorded. I prepare. I do not improvise on policy questions outside my jurisdiction-experience.
Request a bookingMedia kit (PDF)
Bio in three lengths (50 / 200 / 500 words), high-resolution photo, credential summary, and approved boilerplate language. Available on request.
Request media kitQuote / comment requests
For working journalists with a deadline: send me the question and your deadline. I respond within 24 hours during the working week, faster if it's tight.
Send a querySpeaking engagements
I take a small number of speaking engagements per year — conferences, panels, regulator briefings. Honoraria expected for commercial events; pro bono for patient-advocacy contexts.
Request a date